1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6232CE75A7BC6CDBE0025877A00470D76
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/insights/pharma-digital-transformation-is-your-organization-ahead-or-behind-of-the-curve?opendocument
18
19opendocument
203.89.204.127
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25Main






Pharma’s Digital Transformation: Is your organization ahead or behind of the curve?

CHAPEL HILL, N.C., Sep. 07, 2020/PRNewswire/ -- The COVID-19 pandemic has upended nearly every aspect of the biopharma engagement model; at the same time, it has accelerated the long-awaited digital transformation of the industry.

A new retrospective study by Best Practices, LLC determined that most companies will reassess the use of technology platforms to determine the optimal implementation or mix once the pandemic is over. Any internal tools and platforms that can clearly demonstrate to senior leaders an increased efficiency and effectiveness – particular among key external stakeholders - will gain a strong foothold in the post-COVID world.

"Pharma’s Digital Transformation Turning Point: Disruption, Challenges and Recommendations for Medical and Commercial Leaders" is a 106-page report that reveals the most effective digital strategies, tools and approaches being implemented by forward-looking Medical and Commercial leaders. The study also lays out specific challenges and recommendations for any biopharma leaders seeking to maximize performance and aid the digital growth of their own organization.

The data and insights presented in this report are drawn from 10 benchmark studies conducted by Best Practices, LLC to understand the short-term and long-term steps biopharma organizations are taking to meet new challenges and opportunities arising in the wake of COVID-19. Overall, more than 200 biopharma executives from 178 top companies contributed to this research via survey response data and deep-dive interviews.

Key topics in this research include:

  • Digital Transformation: A Turning Point for Pharma
  • Digital Implementation
  • HCP / External Engagement
  • Virtual Advisory Boards
  • Clinical Trials
  • Patient Engagement
  • Speaker Programs
  • Internal Engagement
  • Technology Platforms
  • Change in Key Performance Indicators

Download a complimentary report summary at: https://www.best-in-class.com/rw104.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.